Skip to main content
VCbacked
Log inGet Started

Mestag Therapeutics

Cambridge, United Kingdom

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

$40.0M raised
Mar 2026
Series Unknown
BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Top Investors

Forbion Capital PartnersSV Health InvestorsGoogle VenturesInnovate UKJohnson & Johnson Innovation

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mestag Therapeutics

How much funding has Mestag Therapeutics raised?
Mestag Therapeutics has raised $40.0M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.
Who are Mestag Therapeutics's investors?
Mestag Therapeutics's investors include Forbion Capital Partners, SV Health Investors, Google Ventures, Innovate UK, Johnson & Johnson Innovation.
Where is Mestag Therapeutics headquartered?
Mestag Therapeutics is headquartered in Cambridge, United Kingdom.
What does Mestag Therapeutics do?
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
What stage is Mestag Therapeutics at?
Mestag Therapeutics is at the Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Mestag Therapeutics — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/mestag-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Mestag Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mestag-therapeutics
Wikipedia (cite web)
{{cite web |title=Mestag Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mestag-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K